News – Page 943 – Endpoints News

A unicorn stalks Wall Street in search of IPO cash; CASI Pharma in-licenses CD19 therapy from China’s Juventas

7 years ago

Drugmakers sue HHS for trying to add prices to DTC ads

7 years ago

Sanofi Genzyme deserts gene therapy developer Voyager Therapeutics

7 years ago

Investors fret as VBI's hep B vaccine fails key secondary PhIII study goal

7 years ago

As Bristol-Myers/Celgene tie up loose ends, BeiGene pockets $150M from PD-1 breakup

7 years ago

Gene therapy R&D deals turn red hot as Big Pharma steps up to play

7 years ago

Pfizer CEO Albert Bourla is back in the M&A game, but why is he paying $11.4B for Array?

7 years ago

Fueled by early success, Enanta paves way for mid-stage RSV study in adult patients later this year

7 years ago

Philadelphia champions life sciences 'co-working,' reviving former GSK campus in $500M makeover

7 years ago

Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report

7 years ago

Newsmakers at #EHA19: Regeneron, ArQule track progress on response rates

7 years ago

Chi-Med cuts surufatinib PhIII short; FDA greenlights Herceptin copycat from Amgen, Allergan

7 years ago

Tariq Kassum jumps from Obsidian to Celsius helm; Quell Therapeutics taps Iain McGill as new CEO

7 years ago

Under siege, investment manager Woodford faces another investment shock

7 years ago

BeiGene touts 'encouraging' response rates as the Chinese biotech mounts challenge to BTK, PD-1 leaders

7 years ago

Global Blood Therapeutics poised to submit application for accelerated approval, with new pivotal data on its sickle ...

7 years ago

Bluebird shares sink as analysts puzzle out $1.8M sticker shock and an unexpected delay

7 years ago

FDA warns of one death linked to fecal transplants

7 years ago

GSK's Barron joins hands with Doudna, Weissman to deploy CRISPR tech in drug discovery

7 years ago

AbbVie touts new data for Humira successor; Gilead inks discovery deal

7 years ago

Turns out, Rudy Tanzi didn't see much of a story about a hidden link between Enbrel and Alzheimer's either

7 years ago

Gene therapies seize the top of the list of the most expensive drugs on the planet — and that trend has just begun

7 years ago

Adding marquee investors, BlackThorn bags $76M to back an AI-driven strategy for precision neuro medicine

7 years ago

J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato

7 years ago

First page Previous page 940 941 942943944 945 946 Next page Last page